The first Adverum Biotechnologies trade was made in Q3 2016.
Since then Ken Griffin bought shares 26 more times and sold shares on 42 occasions. The investor completely sold their stake between Q4 2023 and Q1 2024.
Avg closing price
Price range
Sold -3.37 Thousand shares
Q1 2024
Avg closing price
$3.05
Price range
$0.80
-
$16.06
New holding (+3.37 Thousand shares)
Q4 2023
Avg closing price
$0.91
Price range
$0.75
-
$1.26
Sold -422 shares
Q2 2023
Avg closing price
$1.05
Price range
$0.68
-
$1.59
Sold 47.3% shares (-378 shares)
Q1 2023
Avg closing price
$0.71
Price range
$0.62
-
$0.85
Sold 38.1% shares (-492 shares)
Q4 2022
Avg closing price
$0.76
Price range
$0.54
-
$1.03
Sold 48.8% shares (-1.23 Thousand shares)
Q3 2022
Avg closing price
$1.31
Price range
$0.88
-
$1.75
Sold 67.2% shares (-5.18 Thousand shares)
Q2 2022
Avg closing price
$1.05
Price range
$0.81
-
$1.34
Sold 72.6% shares (-20.5 Thousand shares)
Q1 2022
Avg closing price
$1.46
Price range
$1.23
-
$1.95
Increased shares by 13.1% (+3.27 Thousand shares)
Q4 2021
Avg closing price
$2.00
Price range
$1.74
-
$2.40
Sold 15.9% shares (-4.71 Thousand shares)
Q3 2021
Avg closing price
$2.55
Price range
$2.08
-
$3.60
Sold 25.0% shares (-9.85 Thousand shares)
Q2 2021
Avg closing price
$5.39
Price range
$3.36
-
$10.56
Sold 6.6% shares (-2.79 Thousand shares)
Q1 2021
Avg closing price
$12.01
Price range
$9.26
-
$14.36
Sold 51.1% shares (-44.2 Thousand shares)
Q3 2020
Avg closing price
$14.98
Price range
$10.30
-
$21.64
Sold 24.4% shares (-27.9 Thousand shares)
Q2 2020
Avg closing price
$17.71
Price range
$8.53
-
$25.64
Increased shares by 333.0% (+87.9 Thousand shares)
Q1 2020
Avg closing price
$11.66
Price range
$7.98
-
$16.32
Sold 68.6% shares (-57.7 Thousand shares)
Q4 2019
Avg closing price
$8.81
Price range
$5.12
-
$12.22
Increased shares by 4391.0% (+82.2 Thousand shares)
Q3 2019
Avg closing price
$11.27
Price range
$5.24
-
$15.89
Sold 8.4% shares (-172 shares)
Q2 2019
Avg closing price
$8.27
Price range
$5.10
-
$11.89
Sold 98.7% shares (-149 Thousand shares)
Q1 2019
Avg closing price
$4.04
Price range
$3.03
-
$6.02
Increased shares by 85.6% (+69.9 Thousand shares)
Q4 2018